Indefinite Delivery Contract HHSN268201100007I

Award Date 3/21/11
Last Date to Order 3/14/20
Awardee
Vitalant
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Order Dependent (IDV only)
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
This Indefinite Delivery Contract (IDC) was awarded by the National Heart Lung and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), to Vitalant, a nonprofit organization. The contract, valued at up to $14,202,948, supports the Recipient Epidemiology and Donor Evaluation Study III (REDS-III) Central Laboratory program. Under this single-award IDC, Vitalant's Vitalant Research Institute (VRI) division provides a range of services, including supplying blood products,...
The National Heart, Lung, and Blood Institute (NHLBI), a civilian agency within the Department of Health and Human Services, awarded this Indefinite Delivery Contract (IDC) to Vitalant Research Institute (VRI), the research arm of the non-profit organization Vitalant. The $7,416,000 IDC, which does not have a set-aside designation, is for the REDS-IV-P DOMESTIC HUBS project with a period of performance through March 2026. Under this IDC, VRI has been awarded several delivery orders totaling over...
The federal contract IDV award is for the REDS-IV-P Center for Transfusion Laboratory Studies (CTLS), which was awarded to Vitalant, the research arm of the non-profit organization Vitalant. The National Heart, Lung, and Blood Institute (NHLBI), a civilian agency within the National Institutes of Health, is the funding agency for this single-award Indefinite Delivery Contract, valued at a ceiling of $15,573,000. The contract provides for the delivery of a range of goods and services related to...
The National Heart Lung and Blood Institute (NHLBI), a civilian agency within the Department of Health and Human Services, awarded a single-award Indefinite Delivery Contract (IDC) to Versiti Wisconsin, Inc., a non-profit blood center and transplant organization. The IDC, valued up to $7,416,000, facilitates the recurring annual provision of REDS-IV-P domestic hubs, which involve blood collection, processing, testing, storage, and distribution services to support healthcare facilities,...
This Indefinite Delivery Contract (IDC) was awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 21 (VISN 21) to Vitalant Research Institute (VRI), the research arm of the non-profit organization Vitalant. The single-award contract has a ceiling value of $650,000 and a performance period ending on March 31, 2025. Through this IDC and associated task orders, VRI will provide blood and blood products to support healthcare programs for veterans served by VISN 21....
This Indefinite Delivery Contract (IDC) was awarded by the Indian Health Service (IHS), a civilian agency within the Department of Health and Human Services, to Vitalant, a nonprofit organization, for the provision of blood products and fresh frozen plasma to support healthcare programs serving Native American communities. The contract has a total ceiling value of $417,300 and a performance period from June 30, 2021 through December 31, 2024, with no set-aside designation. Vitalant, through...
This Indefinite Delivery Contract (IDC) was awarded by the U.S. Department of Health and Human Services' National Institute of Child Health and Human Development to the University of Cincinnati, a public research institution. The $3.43M contract, which has a period of performance through March 2011, is for the provision of blood and blood products through the Hoxworth Blood Center. The IDC has facilitated the award of several firm-fixed price delivery orders over the years, ranging from $120,000...
This Indefinite Delivery Contract (IDC) was awarded by the Indian Health Service (IHS), a civilian agency within the U.S. Department of Health and Human Services, to Vitalant, a non-profit organization. The $2,377,000 contract provides for the procurement of blood products and blood components to support the Phoenix Area Office and its associated service units. Vitalant, through its research division Vitalant Research Institute, will deliver a range of blood-related goods and services, including...
The indefinite delivery contract was awarded by the National Institutes of Health (NIH) Clinical Center to The American National Red Cross, doing business as American Red Cross, for the provision of apheresis donor services and supplies in support of NIH clinical protocols. This single-award, $9,954,351.76 contract has a period of performance through March 31, 2026. The contract aims to establish a reliable supply chain for critical blood products and related laboratory testing services to...
This Indefinite Delivery Contract (IDC) was awarded by the National Institutes of Health (NIH) Clinical Center to the American National Red Cross for the procurement of blood and blood products necessary to support patient treatment at the NIH Clinical Center. The contract has a total ceiling value of $1,858,042.75 and a period of performance through March 31, 2025. The IDC allows the NIH Clinical Center to efficiently order a variety of critical blood and blood products, including red blood...
  • HHSN268201100007I
    Indefinite Delivery Contract
  • 3
    Federal Contract Awards

This indefinite delivery contract (IDC) was awarded by the National Heart, Lung, and Blood Institute (NHLBI), a component of the Department of Health and Human Services (HHS), to Vitalant Research Institute (VRI), the research arm of the nonprofit Vitalant organization. The contract, valued at up to $9.47 million, supports the NHLBI's Recipient Epidemiology and Donor Evaluation Study III (REDS-III) International program, which focuses on blood safety and availability issues globally.

Under this IDC, VRI has been awarded multiple delivery orders to provide epidemiological and donor evaluation services for the REDS-III study in Brazil. Key tasks include establishing a sickle cell disease patient cohort, evaluating transfusion strategies and risks, and conducting clinical protocol implementation and data analysis. VRI has subcontracted portions of the work to the University of Sao Paulo, UCSF Benioff Children's Hospital Oakland, and the Fundacao Faculdade de Medicina. The contract has a period of performance through March 2020 and does not utilize any set-asides, with work primarily based in San Francisco, California.

Generated 10/11/24, 9:05 AM